NCT07076303View on ClinicalTrials.gov

A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

March 11, 2002

Primary Completion Date

February 1, 2026

Study Completion Date

June 1, 2026

Conditions
Primary Open Angle GlaucomaGlaucomaPrimary Open Angle Glaucoma or Ocular Hypertension
Interventions
DEVICE

Direct Selective Laser Trabuloplasty

Eligible participants will undergo the DSLT procedure to facilitate controlled aqueous outflow. DSLT will consist of 120 shots, 400 µm spot size, energy 1.4-1.8 mJ delivered at the limbus over 2.4 seconds

Trial Locations (1)

19462

RECRUITING

Shafer Vision Institute, Plymouth Meeting

All Listed Sponsors
lead

Brian Shafer

OTHER